News & Events

Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification

Sep 3, 2010

Sep 3, 2010 – Shanghai, China – WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its manufacturing subsidiary, Shanghai SynTheAll Pharmaceuticals Co. Ltd. (STA) passed the ISO 14001: 2004 inspection conducted by SGS Group on July 1 and received formal ISO 14001 certification on July 30.

Press Releases

05/13/2010
Professor Eric N. Jacobsen Speaks at WuXi AppTec

08/11/2010
WuXi PharmaTech Appoints Edward Hu as Chief Financial Officer

05/12/2010
WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer

03/02/2010
WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training

02/23/2010
WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai

02/22/2010
WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility

01/20/2010
WuXi PharmaTech (NYSE: WX) Welcomes Mr. Wu Bangguo in Its Preclinical Testing Facility

more >

News Archives: 2009 | 2008 | 2007 | 2006 | 2005 | 2004

WuXi AppTec In the News

WuXi Pharmatech Featured in The Fast Company 50 2009
Source: Fast Company, 2/11/2009

Right Mix
Source: ChinaDaily 3/24/2008

New prescription
Source: ChinaDaily 3/24/2008

No Slowdown for China's WuXi
Source: The Motley Fool 3/14/2008

Drug Makers Stick by China
Source: Boston Globe 3/14/2008

China's WuXi gets U.S. okay to buy AppTec
Source: Reuters 1/23/2008

Bringing it back to the States
Source: Contract Pharma 1/22/2008

WuXi's AppTec Deal Is Move For Bigger Market Share
Source: The Wall Street Journal 1/5/2008

Wuxi Makes $160 Million Offer for AppTec of U.S.
Source: Bloomberg 1/4/2008

more >